0001012975-21-000053.txt : 20210203 0001012975-21-000053.hdr.sgml : 20210203 20210203112435 ACCESSION NUMBER: 0001012975-21-000053 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210203 DATE AS OF CHANGE: 20210203 EFFECTIVENESS DATE: 20210203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ATP Life Science Ventures, L.P. CENTRAL INDEX KEY: 0001593440 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-19729 FILM NUMBER: 21584947 BUSINESS ADDRESS: STREET 1: 230 PARK AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10169 BUSINESS PHONE: 212-468-5800 MAIL ADDRESS: STREET 1: 230 PARK AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10169 FORMER COMPANY: FORMER CONFORMED NAME: Apple Tree Partners IV, L.P. DATE OF NAME CHANGE: 20131204 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001593440 XXXXXXXX 12-31-2020 12-31-2020 ATP Life Science Ventures, L.P.

230 PARK AVENUE, SUITE 2800 NEW YORK NY 10169

13F HOLDINGS REPORT 028-19729 N Seth L. Harrison 212-468-5800 /s/ Seth L. Harrison New York NY 02-03-2021 1 3 1295119 false 1 0001593453 028-19730 ATP III GP, Ltd. INFORMATION TABLE 2 appletree.xml Akero Therapeutics, Inc. COM 00973Y108 168435 5830203 SH DFND 0 5830203 0 Chinook Therapeutics, Inc. COM 16961L106 63859 4028937 SH DFND 0 4028937 0 Stoke Therapeutics, Inc. COM 86150R107 1062825 17161713 SH DFND 0 17161713 0